Medical Devices; General Hospital and Personal Use Devices; Classification of the Whole Room Microbial Reduction Device
- Published
- Sep 10, 2026
- Effective
- Sep 10, 2026
- Citation
- 91 FR 57507
- Docket
- Docket No. FDA-2026-N-9909
- Agencies
- DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration
Final amendment; final order.
Summary
The Food and Drug Administration (FDA) has officially placed “whole‑room microbial reduction devices” – equipment used in hospitals and other health‑care settings to lower airborne germs throughout an entire room – into a Class II category. Class II devices must meet specific “special controls” that the agency has now defined, which are intended to ensure the devices are safe and work as advertised. By assigning this classification, the FDA aims to protect patients while also streamlining the approval process so that useful, innovative technologies can reach the market more quickly. The rule is issued by the U.S. Department of Health and Human Services through the FDA and applies to manufacturers, distributors, and health‑care facilities that produce, sell, or use whole‑room microbial reduction devices. These stakeholders will need to follow the new special‑control requirements when seeking FDA clearance or maintaining compliance for existing products. The regulation was published and became effective on September 10, 2026, as noted in the Federal Register (91 FR 57507). Because this is a final rule, there is no additional public comment period; manufacturers must now align their designs, testing, and labeling with the specified controls. The FDA will enforce the classification through its usual review and post‑market surveillance activities, and companies can begin submitting the required documentation to obtain or retain clearance under the new Class II framework.
AI-generated summary — verify against the Federal Register text.
Official abstract
The Food and Drug Administration (FDA) is classifying the whole room microbial reduction device into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the whole room microbial reduction device. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Topics
Track this rulemaking
Get alerts when this document changes status or its comment period closes, plus the bills that connect to it.
Sign up free